The Histone H2A Variant MacroH2A1 Does Not Localize to the Centrosome by Friedman, Nathalie et al.
The Histone H2A Variant MacroH2A1 Does Not Localize
to the Centrosome
Nathalie Friedman
., Michal Barzily-Rokni
., Sara Isaac, Amir Eden*
Department of Cell and Developmental Biology, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel
Abstract
MacroH2A1 is a histone H2A variant which contains a large non-histone C-terminal region of largely unknown function.
Within this region is a macro domain which can bind ADP-ribose and related molecules. Most studies of macroH2A1 focus
on the involvement of this variant in transcriptional repression. Studies in mouse embryos and in embryonic stem cells
suggested that during early development macroH2A can be found at the centrosome. Centrosomal localization of
macroH2A was later reported in somatic cells. Here we provide data showing that macroH2A1 does not localize to the
centrosome and that the centrosomal signal observed with antibodies directed against the macroH2A1 non-histone region
may be the result of antibody cross-reactivity.
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Introduction
MacroH2A1 is an unusual histone H2A variant. Its N-terminal
domain is 64% identical to canonical histone H2A, while its C-
terminal portion constitutes a large non-histone region (NHR)
which is twice the size of the histone domain [1,2]. Within the
non-histone region is a protein domain known as the macro
domain which was shown to bind ADP-ribose and related small
molecules [3], but its function remains mostly unknown. In
addition, the NHR has a less characterized linker with no known
homology [4].
Most studies to date implicate macroH2A1 in regulation of gene
expression and particularly in transcriptional repression. Examples
include the recently described involvement of macroH2A in
regulation of gene expression programs during cellular differen-
tiation and development [5,6], the transcriptional repression of
HSP70 by recruitment of Parp1 to the promoter [7], the B-cell-
specific repression of IL-8 [8], and the involvement of macroH2A1
in aberrant silencing of tumor suppressor genes in cancer [9].
Initially, however, most interest has focused on the enrichment
of macroH2A on the inactive X chromosome (Xi) in female
mammalian cells. Using immunofluorescent staining, it was
demonstrated that macroH2A forms so called macro chromatin
bodies (MCBs) representing focal macroH2A1 staining localizing
to inactive but not active X [10,11]. Formation of the MCBs was
shown to be highly dependent upon XIST RNA. That is, removal
of Xist in somatic female cells results in the disappearance of the
MCB [12], while ectopic expression of Xist on autosomes results in
the formation of ectopic MCB [13].
X-inactivation occurs during early embryo development. In pre-
implantation female embryos, both X chromosomes are transcrip-
tionally active. Immediately before gastrulation, either the mater-
nally or the paternally derived X chromosome is inactivated in the
embryo proper [14,15]. The sequence of events during the process
of X-inactivation can be analyzed in female embryonic stem cells
which undergo X-inactivation once induced to differentiate [16].
CombiningRNAfluorescenceinsitu hybridization(RNA-FISH)for
detection of Xist RNA, with immunostaining against macroH2A1-
NHR, showed that macroH2A enrichment at the Xi is a late event
in the inactivation process suggesting macroH2A may be important
for maintenance rather than establishment of the inactive state
[13,17]. A role for macroH2A1 in the silencingof Xi genes was later
demonstrated [18,19].
In undifferentiated ES cells (before X-inactivation), immuno-
staining with an antibody against macroH2A1-NHR further
detected a densely stained region that did not co-localize with X
chromosome(s) [20]. This structure was identifiedas the centrosome
[21] and was also observed in early mouse embryos [22].
Time course analysis of macroH2A1 localization in differenti-
ating female ES cells suggested that centrosomes of undifferenti-
ated cells harbor a substantial store of macroH2A1 which is
shuttled to chromatin and to the Xi upon differentiation. These
observations suggested that macroH2A localization is develop-
mentally regulated and suggested a role for the centrosome in the
X inactivation process [21].
Later studies showed that the centrosomal association of
macroH2A1 is not restricted to undifferentiated ES cells and is
observed in both female and male somatic cells, both in interphase
and in mitosis [22,23].
Our attempt to understand the significance of macroH2A
centrosomal localization resulted in several unexpected findings
which lead us to conclude that macroH2A protein is not associated
with the centrosome and that the centrosomal signal may be the
result of antibody cross-reactivity.
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GFP-MacroH2A fusion protein does not localize to the
centrosome
In an attempt to study the localization of macroH2A to the
centrosome we generated a GFP fusion of macroH2A1. We
observed localization of macroH2A1-GFP to chromatin and to the
inactive X, in the form of macro-chromatin bodies (MCBs).
However, we did not observe localization of GFP to the
centrosome (Figure 1A). This was the case for all three macroH2A
variants, in several cell types. Replacing GFP with RFP or moving
the fusion from the C-terminus to N-terminus did not facilitate
localization to the centrosome (data not shown). On the other
hand, when the same cells containing tagged macroH2A1 where
stained with the macroH2A1-NHR antibody, centrosomal stain-
ing was observed (Figure 1B).
Centrosomal staining is evident in MacroH2A1 deficient
cells
In light of these results, we examined macroH2A1 localization
in mouse embryonic stem cells (mESCs) in which both alleles of
macroH2A1 are genetically targeted (Figure S1). Western blot
analysis indicates complete loss of macroH2A1 at the protein level
in these cells (Figure 2A). In immunofluorescence, wild type ES
cells show nuclear staining as well as strong centrosomal staining.
However, in macroH2A1 KO cells the nuclear macroH2A1
staining was lost while centrosomal staining was still evident
(Figure 2B).
Knock down of macroH2A1 removes nuclear but not
centrosomal staining
The targeting approach used for generating macroH2A1
knockout mESCs removes only the second exon of the gene
(containing the ATG) and obliterates the entire protein (Figure S1).
However, the non histone region(NHR),which wasused to develop
antibodies against macroH2A1 is encoded by exons 5–10 [24]. It is
therefore theoretically possible that the protein detected by the
antibody is encoded by an alternative transcript which is not lost in
the targeted cells and somehow not detected by western blot.
To test this possibility, we used a lentiviral vector carrying
shRNA to stably knockdown macroH2A1 (Figure 3). This shRNA
targets a sequence within the NHR and should eliminate all
transcripts running through this region. As before, nuclear staining
was significantly reduced as a result of the knockdown, while
centrosomal staining was unaffected even several weeks after the
shRNA transduction and selection (Figure 3 and Figure S2a).
Concurrent abolishment of macroH2A1 and macroH2A2
leaves centrosomal staining intact
We considered the possibility that the antibody developed
against macroH2A1 could cross react with the macro domain of
macroH2A2 and that macroH2A2 was responsible for the
centrosomal staining (although the macroH2A1-NHR antibody
does not recognize macroH2A2 in western blots). Using
macroH2A2 knockout ES cells (Figure 4A), and even macroH2A2
knockout ES with knockdown of macroH2A1, the centrosomal
staining was still apparent indicating that none of the three
macroH2A variants is responsible for the centrosomal signal
(Figure 4B). Here again, quantification of centrosomal staining
intensity indicated no significant difference between control and
KO/KD cells (Figure S2b).
Affinity purified macroH2A isoform specific antibodies do
not stain the centrosome
Studies that report centrosomal localization of mH2A1 [21,22]
used an antibody described in [10] [25] which was developed
Figure 1. GFP fused macroH2A is not localized to the centrosome. A. WI-38 cells were transfected with GFP-macroH2A1 and immune-stained
for c-Tubulin as a marker of the centrosome (Red). B. WI-38 cells were co-stained for c-Tubulin (red) and macroH2A1-NHR antibody (Green). DNA
stained with DAPI (Blue). Bar indicates scale of 10 mm.
doi:10.1371/journal.pone.0017262.g001
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ly, when we used an isoform specific antibody which was
developed using a specific peptide and was affinity purified using
this peptide (mH2A1.2 amino acids 198–228) [26] only nuclear
staining was detected (Figure 5).
Western blot analysis using non-denaturing gel reveals
additional band when using macroH2A1-NHR antibody
We suspected that the centrosomal signal may be caused by
cross reactivity of the antibody with a different protein which is
detected by the antibody on fixed cell samples but not following
denaturation and western blot. We therefore checked if perform-
ing western analysis under less denatured conditions might
facilitate the identification of an additional protein. Indeed when
b-mercaptoethanol was omitted from the sample buffer, an
additional band at the size of ,100 kDa was observed. This band
was not observed in samples containing b-mercaptoethanol
(Figure 5C). Importantly, this second band observed using non-
reducing conditions remained when investigating macroH2A1
knock-out samples (Figure 5C), indicating that it cannot be a
multimeric version of macroH2A1. Moreover, exposing the same
gel to the affinity purified variant specific antibody obliterated this
band also in the non-denaturing conditions (Figure 5C). Thus, the
presence of this band in western analysis is in full agreement with
the presence of centrosomal staining, suggesting that the additional
band might be the source of the centrosomal macroH2A1 artifact.
Discussion
We provide several lines of evidence which are inconsistent with
centrosomal localization of macroH2A1: First, we find that GFP-
tagged macroH2A variants show no centrosomal signal (Figure1 and
data not shown). This is in agreement with other studies that used
FLAG tagged macroH2A and also fail to observe macroH2A at the
centrosome in somatic cells and in mouse oocytes early embryos
[23,27]. In addition, when using the macroH2A1-NHR antibody for
immunofluorescence in macroH2A1 deficient cells, whether
macroH2A1 KO or KD, the centrosomal signal remains (Figures 2
and 3). The centrosomal signal also persists when cells are deficient in
both the macroH2A1 and macroH2A2 variants (Figure 4). We
further provide evidence indicating thatunder more native conditions
macroH2A1-NHR antibody can cross react with a different protein
with apparent molecular weight of ,100kDa (Figure 5C), suggesting
that the centrosomal staining which is characteristic of this antibody
may be the result of antibody cross-reactivity.
The initial reports detecting macroH2A at the centrosome used
a polyclonal antibody raised against the whole NHR of
macroH2A1.2 [10]. Later reports, including the current study,
Figure 2. MacroH2A1-NHR antibody show centrosomal staining in macroH2A1 KO cells. A. Western blot of wt ES and macroH2A1 KO
using the macroH2A1-NHR antibody confirms absence on macroH2A1 in knockout cells. B. Wt and macroH2A1 KO ES cells were stained with
antibodies against c-Tubulin (red) and macroH2A1-NHR (green). DNA stained with DAPI (Blue). Bar indicates scale of 10 mm.
doi:10.1371/journal.pone.0017262.g002
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same epitope [25] and show the same apparent cross reactivity. In
contrast, when a small portion of the protein was used to raise an
antibody [26], it failed to identify the centrosome (Figure 5A and
B). In itself, antibody cross reactivity is not unusual. However the
possibility that it occurred with two independent antibody
preparations and is apparent only under more native conditions
suggests that there is a spatially similar structure on a different
protein which is found at the centrosome. One reasonable
possibility is that the antibody cross-reacts with a macro domain
of another protein. There are at least 28 additional human
proteins with a macro domain. None of them was reported to be
found at the centrosome, but our results do not exclude this
possibility.
In addition to immunofluorescence, both [21,22] provide
biochemical support to the presence of macroH2A1 in the
centrosome by showing macroH2A in preparations of centro-
somes. While normally this can be considered strong experimental
confirmation, both studies used a protocol based on Mitchison and
Kirschner [28,29]. Importantly, in their protocol, Mitchison and
Kirschner specifically mention that in interphase cells the
centrosome is tightly attached to the nucleus and discuss at length
the difficulties in separating the two. It is therefore possible that
macroH2A detected in centrosome preparations was the result of
contamination by nuclear material.
Chadwick et al propose that macroH2A may be shuttled to the
centrosome for proteasomal degradation [23]. In our analysis we
find the centrosomal signal even in macroH2A1 knockout or
knockdown cells which are completely devoid of the nuclear
protein (Figures 2 and 3). These results suggest that the origin of
the centrosomal protein cannot be the nuclear full length
macroH2A.
To conclude, while we do not identify the component responsible
for the centrosomal signal observed with macroH2A1-NHR
antibody, we provide strong evidence this signal does not represent
macroH2A1.
Materials and Methods
Cell culture
Mouse ES cell line V6.5 [30] were grown without feeders in
DMEM supplemented with 10% fetal calf serum (FCS), penicillin
(50 mg/ml), streptomycin (50 mg/ml) and 2 mM (L-Glutamine),
0.1 nM non essential amino acids (NEAA), 0.1 mM b-Mercapto-
ethanol and 2610
3units/ml Leukocyte Inhibitory Factor (LIF).
HEK293T [31] cells were cultured in DMEM medium and Tert-
immortalized WI-38 cells ([32], ATCC number CCL-75) in MEM
Both media were supplemented with 10% fetal calf serum (FCS),
penicillin (50 mg/ml), streptomycin (50 mg/ml) and 2 mM (L-
Glutamine). In addition, WI-38 medium contained 0.1 nM NEAA
and 1 mM sodium pyruvate.
Antibodies and Western blot analysis
Anti-macroH2A1-NHR polyclonal antibody is described in
[25] and was prepared against the entire non-histone-region as in
[10]. Affinity purified isoform specific Anti-macroH2A1.2 and
Anti-MacroH2A2 were kindly provided by A. Ladurner (EMBL)
[26]; Anti-b-actin (Abcam ab6276); Anti-H2A (Upstate 07-146).
Figure 3. MacroH2A1-NHR antibody shows centrosomal staining in macroH2A1 KD cells. A. Western blot verifying KD efficiency. B. WI-38
were transduced with either a scrambled vector or a macroH2A1 KD Cells were then subjected to immunofluorescence using antibodies against c-
Tubulin (red) and macroH2A1-NHR (green). DNA stained with DAPI (Blue). Bar indicates scale of 10 mm.
doi:10.1371/journal.pone.0017262.g003
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radish peroxidase, FITC or Cy3 (Jackson Immunoresearch
Laboratories).
shRNA lentiviral vectors
Construction of lentiviral vectors pLKO1.puro/hygro carrying
shRNA directed against mouse macroH2A1 was as described [31].
The macroH2A1 target sequence used was 59-CCAGT-
TACTTCGTGTCTACAA-39. Scrambled sequence was 59-
GTTGCCCCTAGACTTAGAACT-39. Viral particles were pro-
duced in 293T cells as described in Moffat et al [31] and target cells
were exposed to two rounds of infection followed by the relevant
selection (2 mg/ml puromycin or 140 mg/ml hygromycin) for
approximately 10 days. Knockdown cells used for the experiments
presented in this study were analyzed weeks after the completion of
selection.
Immunofluorescence: and image analysis
Cells were plated on glass slides the day before the stain, fixed in
4% paraformaldehyde (PFA) for 10 min, and permeabilized for
5 min in 0.2% Triton X-100/PBS. Slides were then incubated in
PBS containing 0.2% Tween 20, blocked with 10% fetal bovine
serum and incubated with primary antibody for 1 h at room
temperature. After three consecutive 5 min washes in 0.2% Tween
20/PBS, cells were incubated for 1 h with secondary antibody and
DAPI followed by three additional washes before mounting [19].
Images were collected on a Nikon TE-2000 inverted microscope
and processed using NIS-element software. Identical camera and
microscope settings were employed to allow valid comparison
between images of control and macroH2A1 deficient cell
populations. In some images the red channel was enhanced to
specifically point out the centrosomal signal of c-tubulin.
Quantification of the Intensity of centrosomal staining on the
green channel (macroH2A1-NHR antibody stains) was performed
on the original exposure using the Image Gauge v 4.0 software.
The centrosomal signal was defined by summing the intensity from
an area representing the centrosome and subtracting the
background intensity of an identical area. For each centrosome
a background signal corresponding to the centrosomal localization
was used (nuclear or cytoplasmic).
Generation of GFP-tagged macroH2A and transfection
Full-length mouse macroH2A variants tagged with enhanced
green fluorescent protein (EGFP) at the C- and N-termini were
generated by cloning PCR amplified cDNA of macroH2A into the
EcoRI sites of pEGFP-C1 and pEGFP-N1 cloning vectors
Figure 4. MacroH2A1-NHR antibody shows centrosomal staining in macroH2A1 and 2 double deficient cells. To generate double
deficient cells macroH2A1 was knocked down in macroH2A2 KO mESCs using stable shRNA lentiviral transduction A. Western blot analysis
confirming absence of macroH2A2, using affinity purified macroH2A2 antibody (left panel), and macroH2A1, using macroH2A1-NHR (right Panel) in
the targeted cells compared to control. B. Wt ESCs and macroH2A1 and 2 double deficient cells were stained with antibodies against c-tubulin (red)
and macroH2A1-NHR (green). Nuclei were stained with DAPI (Blue). Bar indicates scale of 10 mm.
doi:10.1371/journal.pone.0017262.g004
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Transfection of the EGFP-macroH2A1 vectors was performed
using the TransITH-LT1 transfection agent (Mirus) according to
the manufacturer’s protocol.
Supporting Information
Figure S1 Generation of macroH2A1 V6.5 ES KO cells.
A. The second exon of macroH2A1 contains the translation
initiation codon. The next in-frame ATG is close to the end of the
protein and several out-of–frame sites are found between the two.
Thus, removal of exon 2 should completely prevent production of
the protein. The targeting vector included a genomic fragment
that covers exon 2 with flanking regions. LoxP sites (blue triangles)
and the Hygro-TK (HTK) selection marker were inserted as
shown. After transient exposure to Cre recombinase and selection
with Ganciclovir two versions were obtained: in one version exon
2 was removed producing a null allele (N), in the second version
only the HTK cassette was lost producing a conditional allele that
can be looped out in a later stage to produce a null allele. On the
left pane: Southern blot analysis (using a probe from macroH2A1
exon 3) demonstrating the correct targeting of ES cells carrying a
targeted allele (T/+) a conditional allele (C/+) or a null allele (N/
+). In C/+ cells the targeting procedure was repeated and after
transient exposure to Cre recombinase, N/N cells were obtained.
B. Western blot using the macroH2A1-NHR antibody confirms
that knockout (N/N) cells do not express macroH2A1 in.
Coomassie stain is used as loading control.
(TIF)
Figure S2 MacroH2A knockout or knockdown does not
affect centrosomal staining intensity. Intensity of cen-
trosomal staining was measured on the green channel
using the Image Gauge v 4.0. The centrosomal signal was
defined by summing the intensity from an area representing the
centrosome and subtracting the background intensity of an
identical area. For each centrosome a background signal
corresponding to the centrosomal localization was used (nuclear
or cytoplasmic). Graph shows average intensity of centrosomal
signal (arbitrary units +/-SD, N=10) in A: cells transduced with
either control or macroH2A1 shRNA (corresponding to Figure 3).
B: wt mESCs compared to macroH2A2 KO cells transduced with
macroH2A1 shRNA (corresponding to Figure 4).
(EPS)
Figure 5. Affinity purified variant specific macroH2A1.2 antibody show no centrosomal staining. Wt ES cells were stained with antibodies
against either (A) the macroH2A1-NHR antibody (green) or (B) with the affinity purified variant specific macroH2A1.2 together with c-Tubulin (red).
Nuclei were stained with DAPI (Blue) C. Protein samples were collected from wt ES and macroH2A1 KO ES in SDS containing sample buffer with or
without b-mercaptoethanol. Western Blot analysis was done using anti-MacroH2A1-NHR or anti-MacroH2A1.2 isoform specific affinity purified antibody.
doi:10.1371/journal.pone.0017262.g005
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